Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension
Markus P. Schlaich(Friedrich-Alexander-Universität Erlangen-Nürnberg), Murray Esler(Baker Heart and Diabetes Institute), Élisabeth Lambert(Baker Heart and Diabetes Institute), Paul A. Sobotka(The Ohio State University), Henry Krum(Monash University)
Cited by 774
Related Papers
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
|The Lancet|2010|2.2k
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
|The Lancet|2009|2.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure
|Circulation|2004|1.2k
Aliskiren, ALTITUDE, and the Implications for ATMOSPHERE
|European Journal of Heart Failure|2012|1.1k